{"schema_version":"secwatch.filing_event.v1","accession":"0001370053-23-000058","form_type":"8-K","ticker":"ANAB","cik":"0001370053","company_name":"ANAPTYSBIO, INC","filed_at":"2023-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.778360+00:00","generated_at":"2026-06-09T10:03:22.357796+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"AnaptysBio presents R&D slide deck on PD-1 agonist rosnilimab","bullets":["Presented rosnilimab (PD-1 agonist) R&D slide presentation on October 25, 2023.","No specific clinical data, milestones, or financial guidance disclosed in the filing.","Presentation provided as Exhibit 99.1; not filed, only furnished under Regulation FD."],"urls":{"canonical":"https://secwatch.observer/filing/0001370053-23-000058","json":"https://secwatch.observer/filing/0001370053-23-000058.json","markdown":"https://secwatch.observer/filing/0001370053-23-000058.md","text":"https://secwatch.observer/filing/0001370053-23-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000058/0001370053-23-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000058/anab-20231025.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T10:03:22.357796+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}